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Background
Recent advances in genotyping techniques and genomic
knowledge via the Hap Map and Human Genome
projects allow for true Genome-Wide Association (GWA)
analysis for common complex diseases such as heart dis-
ease, diabetes, and Alzheimer's. A major obstacle in GWA
analysis is the prohibitively high cost of genotyping the
possibly thousands of individuals necessary to achieve
statistical significance of results. One potential solution is
to pool the DNA of case and control populations and to
determine the genotype allele frequency differences in
these populations by pooled allelotyping. While pooling
can dramatically save time and money, it also adds
sources of error. Our work has created a system process
that allows for direct evaluation and comparison of
pooled allelotyping to individual genotyping for GWA
association analysis of complex disease.
Materials and methods
Complex disease penetrance functions were calculated for
a 3 locus bi-allelic model with additive or multiplicative
allelic spectrums using GenomeSIM software [1]. Pene-
trance probabilities were calculated for genotypes having
from 0 to 6 disease-associated alleles. All probability func-
tions used a base penetrance probability of 10% disease
risk to account for environmental influences on disease
risk. A total of 25,000 individual genotype files were cre-
ated, each comprised of 10,000 SNPs with 3 disease-asso-
ciated loci imbedded within. Custom MATLAB scripts
were used to make in silico "pseudo-pools" for pooled
allelotyping from the individual genotype files. HAPLOV-
IEW software was used to conduct individual genotyping
association analysis [2]. A modified version of the Pooled
DNA Analyzer (PDA) program was used for pooled asso-
ciation analysis [3].
Conclusion
Power analysis was conducted for individual genotyping
and pooled allelotyping with allele frequency estimation
error from levels from 1% to 5% (see Figure 1). Our
results show that pooling errors have a very large effect on
the overall statistical significance of a pooled GWA study.
Even a pooling error of 1% shifted the minimum resolva-
ble relative risk (RR) with 80% power from (1.33–1.5) in
individual genotyping to (1.5–1.67) in pooling. Pooling
with 2% error had a minimum resolvable RR of (1.67–
1.83). Pooling with 3% error resolved at RR (2.0–2.33).
Further, pooling with 4% and 5% error of was not able to
achieve 80% power at any of the levels of relative risk
tested. Thus, pooled GWA studies may be limited to
resolving complex disease associated variants with
medium to high relative risks ratios.
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Association analysis power curve for individual genotyping versus pooled allelotyping Figure 1
Association analysis power curve for individual genotyping versus pooled allelotyping. Individual genotyping: red 
dashed lines. Pooled allelotyping with 1% to 5% allele frequency estimation error: blue solid lines. Power is defined as the per-
cent of simulations where disease associated loci had association test p-values more significant than (p-value < 0.05). Results 
are the average of 100 simulations at each of the relative risk levels listed on the X-axis.